Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia

B. Basarik, P. Ozdemir, M. S. Tasbakan, O. Kacmaz Basoglu, A. Gurgun, F. Bacakoglu (Istanbul, Turkey)

Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Session: The new clinical spectrum of lung diseases: from bronchi to pleura
Session type: Poster Discussion
Number: 490
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Abstract

Introduction and Aim
Clinical pulmonary infection score (CPIS) is a scoring system calculated by symptoms and signs of pneumonia, that is used in the diagnosis and management of hospital acquired pneumonia (HAP). In this study, the contribution of CPIS for diagnosis of HAP was investigated in intensive care unit (ICU) patients.
Methods
The ICU patients followed-up between February 2008 and September 2010 were assessed retrospectively. Hospital acquired pneumonia was diagnosed by quantitative endotracheal aspirate (ETA). CPIS was calculated on 3rd and 7th days of ICU admission. The correlations of CPIS with concurrent ETA cultures and laboratory markers of infection were assessed.
Results
Out of 240 patients (165 men, mean age 58.2±16.6 yrs) included in the study, ETA cultures were positive in 61 patients (25.4%) on 3rd day, and in 59 patients (24.6%) on 7th day. CPIS was found higher in patients with ETA culture positive (5.0±2.3 vs. 3.5±2.1 on 3rd day, p<0.0001; 5.2±2.6 vs. 3.6±2.9 on 7th day, p<0.0001). Sensitivity and specificity ratios of CPIS with a threshold level of 6.5 in diagnosis of HAP were 26.2% and 92.3% for 3rd day; 30.5% and 91.9% for 7th day, respectively. On 3rd and 7th days, there were positive correlations between CPIS and C-reactive protein (CRP) levels (p=0.002 and p=0.001, respectively); and also between CPIS and procalcitonin (PCT) levels (p=0.012 and p<0.0001, respectively).
Conclusion
Clinical pulmonary infection score can be used instead of infection markers like CRP and PCT in the diagnosis of hospital acquired pneumonia.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Basarik, P. Ozdemir, M. S. Tasbakan, O. Kacmaz Basoglu, A. Gurgun, F. Bacakoglu (Istanbul, Turkey). Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia. Eur Respir J 2011; 38: Suppl. 55, 490

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Comparison of CPIS (clinical pulmonary infection score) and clinical criteria in the diagnosis of ventilator associated pneumonia in ICU complex patients
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007


Late-breaking abstract: Evaluation of CRP, PCT, clinical pulmonary infection score and pneumonia severity scores for the diagnosis and prognosis of nursing home acquired pneumonia
Source: Annual Congress 2011 - Early diagnosis in primary care
Year: 2011



Utility of chest echography and pulmonary infection score in early diagnosis of ventilator associated pneumonia
Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Year: 2018

Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

Defining community-acquired pneumonia severity on presentation to hospital: a derivation study
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004

Differential diagnosis of outpatient pneumonia and infiltrative pulmonary tuberculosis by the Diaskintest®
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Comparison of pneumonia severity scoring methods in identification of severe community acquired pneumonia
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Physician judgement is a crucial adjunct to pneumonia severity scores in low-risk patients
Source: Eur Respir J 2011; 38: 643-648
Year: 2011



Severe community acquired pneumonia: clinical and aetiological evaluation
Source: Eur Respir J 2007; 30: Suppl. 51, 673s
Year: 2007

Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Predictive models for pulmonary tuberculosis diagnosis in respiratory syntomatic outpatients
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008

Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006

Epidemiological features of nosocomial tuberculosis in patients with pulmonary tuberculosis in TB hospital
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Interpretation of biomarkers at emergency department depends on onset of symptoms in community-acquired pneumonia
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Pulmonary tuberculosis in the differential diagnosis of community-acquired pneumonia
Source: Eur Respir J 2012; 40: 279
Year: 2012


Does the management and outcome of community-acquired pneumonia differ depending on the route of admission to hospital?
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009


Lung vessel thrombosis like the reason of mortality at severe community-acquired pneumonia (CAP) of viral and bacterial etiology - autopsy data
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018